Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 3,650.00
+10.00 (0.27%)
Last updated: Nov 6, 2025, 9:23 AM KST
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 100.75 billion as of November 5, 2025. Its market cap has decreased by -17.27% in one year.
Market Cap
100.75B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
60.33
Stock Price
3,650.00
Market Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 100.75B, an increase of 250.12%. That is a compound annual growth rate of 4.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 101.02B | 1.81% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | 212.94B | 47.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.84T |
| ALTEOGEN | 29.36T |
| SK Biopharmaceuticals | 9.42T |
| Yuhan | 9.01T |
| HLB Co., Ltd. | 7.03T |
| Peptron | 6.33T |
| ABL Bio | 6.13T |